Triamcinolone Hexacetonide Injection — FDA Drug Shortage

Current — Medexus

The FDA lists a drug shortage record for Triamcinolone Hexacetonide Injection (injection) from Medexus with status Current. The shortage was first posted on 05/04/2021. Reported reason: Delay in shipping of the drug

Shortage Details

Status
Current
Company
Medexus
Package NDC
59137-570-01
Dosage Form
Injection
Presentation
Hexatrione, Injection, 40 mg/2 mL (NDC 59137-570-01)
Initial Posting
05/04/2021
Revised Date

Reason

Delay in shipping of the drug